
Pruritus Therapeutics
Description
Global Pruritus Therapeutics Market to Reach US$16.3 Billion by 2030
The global market for Pruritus Therapeutics estimated at US$12.5 Billion in the year 2024, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the Antihistamines segment is estimated at 4.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 4.3% CAGR
The Pruritus Therapeutics market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
Global Pruritus Therapeutics Market - Key Trends and Drivers Summarized
Alleviating Discomfort: The Expanding Market for Pruritus Therapeutics
Pruritus, commonly known as itching, is a pervasive symptom associated with numerous dermatological, systemic, and neurological disorders, significantly impacting the quality of life of millions worldwide. Conditions such as atopic dermatitis, psoriasis, chronic kidney disease, and liver disease are often accompanied by persistent and severe pruritus, necessitating effective therapeutic interventions. The growing prevalence of these conditions, coupled with an aging population that is more susceptible to chronic diseases, has led to an increased demand for advanced pruritus therapeutics. This market encompasses a wide range of treatments, including topical corticosteroids, antihistamines, immunomodulators, and novel biologics that target the underlying mechanisms of pruritus. The unmet need for effective and long-lasting relief from itching has driven significant research and development efforts aimed at discovering new therapeutic options.
How Are Technological and Pharmaceutical Innovations Influencing the Market?
Technological and pharmaceutical innovations are playing a pivotal role in advancing pruritus therapeutics. The development of biologics and small-molecule inhibitors that target specific pathways involved in the sensation of itching represents a significant breakthrough in this field. These advanced therapies, such as IL-4 and IL-13 inhibitors for atopic dermatitis and kappa-opioid receptor agonists, offer targeted relief by modulating the immune response or neurological pathways associated with pruritus. Additionally, the use of transdermal delivery systems and novel formulation technologies has improved the efficacy and patient adherence to topical treatments. Furthermore, advancements in diagnostic tools and biomarkers are enabling more precise identification of the underlying causes of pruritus, allowing for more personalized treatment approaches. These innovations are transforming the landscape of pruritus therapeutics, offering hope to patients who suffer from chronic and refractory itching.
What Role Do End-User Segments Play in the Adoption of Pruritus Therapeutics?
The adoption of pruritus therapeutics varies across different end-user segments, including hospitals, dermatology clinics, and home care settings. Hospitals and specialized clinics are the primary centers for the administration of advanced biologics and other systemic treatments for severe cases of pruritus, particularly in patients with complex underlying conditions such as chronic kidney disease or cancer. Dermatology clinics, on the other hand, are more focused on managing pruritus associated with skin disorders, using a combination of topical treatments and patient education to manage symptoms. Home care settings are increasingly adopting over-the-counter antihistamines and topical corticosteroids for mild to moderate pruritus, driven by the convenience and ease of access to these treatments. The rise of telemedicine and remote consultations is also facilitating the management of pruritus in home care settings, allowing patients to receive personalized treatment recommendations without the need for frequent clinic visits.
What Are the Key Growth Drivers in the Market?
The growth in the pruritus therapeutics market is driven by several factors. The increasing prevalence of dermatological and systemic conditions that cause chronic itching, such as atopic dermatitis and chronic kidney disease, is a major driver. Technological advancements in drug development, particularly the emergence of biologics and targeted therapies, have significantly expanded treatment options for pruritus, especially in cases that are refractory to traditional treatments. The growing adoption of personalized medicine, supported by advancements in diagnostics and biomarkers, is also driving the market, as treatments can be tailored to the specific needs of individual patients. Additionally, the expansion of telemedicine and the availability of over-the-counter treatments are making pruritus therapeutics more accessible to a broader population, further supporting market growth. As awareness of the impact of chronic pruritus on quality of life increases, the demand for effective and innovative therapies is expected to continue to rise.
SCOPE OF STUDY:The report analyzes the Pruritus Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics, Other Products)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 38 Featured) -
- Abbott Laboratories
- Allergan PLC
- Almirall SA
- Astellas Pharma, Inc.
- Bristol-Myers Squibb Company
- Cipla Ltd.
- Eisai Co., Ltd.
- Eli Lilly and Company
- Galderma SA
- GlaxoSmithKline PLC
- Glenmark Pharmaceuticals Ltd.
- Ipca Laboratories Ltd.
- Lupin Ltd.
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co., Ltd.
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Pruritus Therapeutics – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- Global Economic Update
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Skin Disorders Propels Market Growth
- Increasing Awareness of Pruritus and Its Impact Expands Addressable Market Opportunity
- Technological Advancements in Dermatological Treatments Strengthen Market Position
- Surge in Demand for Effective Itch Management Solutions Generates New Opportunities
- Development of Novel Anti-Pruritic Drugs Sustains Market Growth
- Expanding Applications in Chronic and Systemic Conditions Throws Spotlight on Market Potential
- Growth in Geriatric Population Spurs Demand for Pruritus Therapeutics
- Rising Adoption of Biologic Therapies for Severe Pruritus Propels Market Expansion
- Surge in Demand from Emerging Markets Expands Market Horizons
- Innovations in Topical and Systemic Treatments Generate New Market Opportunities
- Increasing Focus on Addressing Pruritus in Rare Diseases Accelerates Market Growth
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Pruritus Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Pruritus Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Pruritus Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Pruritus Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Antihistamines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Antihistamines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Counterirritants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Counterirritants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Counterirritants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Immunosuppressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 16: World 15-Year Perspective for Immunosuppressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Local Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 19: World 15-Year Perspective for Local Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 22: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 23: USA Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 25: USA 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 28: Canada 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- JAPAN
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 29: Japan Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: Japan Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 31: Japan 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- CHINA
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 32: China Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: China Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 34: China 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- EUROPE
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 35: Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: Europe Historic Review for Pruritus Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 37: Europe 15-Year Perspective for Pruritus Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 38: Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: Europe Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: Europe 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- FRANCE
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 41: France Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: France Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: France 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- GERMANY
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 44: Germany Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Germany Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: Germany 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- ITALY
- TABLE 47: Italy Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Italy Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Italy 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 50: UK Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: UK Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: UK 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Rest of Europe Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Rest of Europe 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Pruritus Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Asia-Pacific Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Asia-Pacific 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- REST OF WORLD
- TABLE 59: Rest of World Recent Past, Current & Future Analysis for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Rest of World Historic Review for Pruritus Therapeutics by Product - Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Rest of World 15-Year Perspective for Pruritus Therapeutics by Product - Percentage Breakdown of Value Sales for Corticosteroids, Antihistamines, Counterirritants, Immunosuppressants, Local Anesthetics and Other Products for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates